Tidal Investments’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,525
Closed -$271K 2814
2026
Q1
$271K Sell
15,525
-2,061
-12% -$40.9K ﹤0.01% 2079
2025
Q4
$345K Buy
17,586
+1,548
+10% +$32.1K ﹤0.01% 1813
2025
Q3
$442K Sell
16,038
-868
-5% -$26.7K ﹤0.01% 1632
2025
Q2
$516K Buy
16,906
+5,318
+46% +$151K ﹤0.01% 1382
2025
Q1
$313K Sell
11,588
-950
-8% -$30.1K ﹤0.01% 1531
2024
Q4
$450K Sell
12,538
-624
-5% -$23.3K ﹤0.01% 1434
2024
Q3
$499K Hold
13,162
0.01% 1387
2024
Q2
$595K Buy
+13,162
New +$606K 0.01% 1211

Other funds holding USNA

Tidal Investments's USNA Position: Q2 2026 in Review

Tidal Investments sold out of Usana Health Sciences (USNA) in Q2 2026, closing a stake of 15,525 shares — an estimated $271K sold.

Tidal Investments first reported a position in USNA in Q2 2024 and held it in 8 quarters. The position peaked at $595K in Q2 2024. 137 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

  • Tidal Investments reported no remaining Usana Health Sciences position as of Q2 2026 after selling out during the quarter.
  • Tidal Investments sold 15,525 Usana Health Sciences shares in Q2 2026, an estimated $271K.
  • Tidal Investments first reported a position in Usana Health Sciences in Q2 2024 and held it in 8 quarters.
  • Tidal Investments's Usana Health Sciences position peaked at $595K in Q2 2024.
  • 137 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.